Attached files

file filename
EX-23 - CONSENT OF STEGMAN AND COMPANY - HEMAGEN DIAGNOSTICS INCdex23.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - HEMAGEN DIAGNOSTICS INCdex321.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - HEMAGEN DIAGNOSTICS INCdex311.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - HEMAGEN DIAGNOSTICS INCdex312.htm
10-K - ANNUAL REPORT - HEMAGEN DIAGNOSTICS INCd10k.htm

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

Pursuant to 18 U.S.C. §1350, as adopted pursuant to

§906 of the Sarbanes-Oxley Act of 2002

In connection with the filing with the Securities and Exchange Commission of the Annual Report of Hemagen Diagnostics, Inc., the “Company”, on Form 10-K for the period ending September 30, 2009, (the “Report”), I, Catherine M. Davidson, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: December 18, 2009     /s/    CATHERINE M. DAVIDSON        
    Catherine M. Davidson
    Principal Financial Officer